Africa
Americas
Asia Pacific
China
Europe
Global
India
Japan
Korea
Latin America
Middle East
Singapore

Marketplace Donate Now Become a Member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Global Events

Holiday Inn London Kensington Forum

Feb 27, 2017 8:00 AM - Mar 03, 2017 1:30 PM

97 Cromwell Road, London, SW7 4DN, United Kingdom

Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing

The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.

Back to Agenda

Topic 2 Session 2: The Role of the Qualified Person Responsible for Pharmacovigilance

Speaker(s)

The Role of the Qualified Person Responsible for Pharmacovigilance

Louise Larham

EU Regional Safety Lead, Global Patient Safety, Amgen Limited, United Kingdom

Have an account?

Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing

Topic 2 Session 2: The Role of the Qualified Person Responsible for Pharmacovigilance

Speaker(s)

Be informed and stay engaged.